论文部分内容阅读
通过对75例脑出血合并脑梗塞住院病人的研究，探讨一定剂量的钙离子拮抗剂（尼莫地平、硝苯吡啶）对出血－梗塞型混合性卒中的治疗效果。方法：随机分为治疗组50例，对照组25例。对照组采用清除血肿、降颅压、营养脑细胞等常规治疗；治疗组在上述常规治疗的基础上，加用一定剂量的硝苯吡啶或尼莫地平。结果：两组间比较有效率和显效率均有显著差异（P＜0．05）。提示脑出血患者治疗过程中应警惕脑梗塞的发生；出血合并梗塞早期应用尼莫地平或硝苯吡啶，可显著提高治疗效果，改善预后；无副作用。
Through the study of 75 cases of cerebral hemorrhage complicated with cerebral infarction inpatients, to explore the dose of calcium antagonists (nimodipine, nifedipine) on bleeding-infarction-type mixed stroke treatment. Methods: Randomly divided into treatment group 50 cases, control group 25 cases. The control group was treated by conventional methods, such as hematoma removal, intracranial pressure reduction and nutritional brain cells. The treatment group was given nifedipine or nimodipine in the above conventional treatment. Results: There was a significant difference between the two groups in the effective rate and markedly effective rate (P <0.05). Tip cerebral hemorrhage in patients with treatment should be alert to the occurrence of cerebral infarction; hemorrhage with infarction early application of nimodipine or nifedipine, can significantly improve the treatment effect and improve the prognosis; no side effects.